High plasma leptin is not associated with higher bone mineral density in insulin-resistant premenopausal obese women

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 5, 2005, Pages 2588-2594

  Samra, Rania Abou ^a   Baba, Nahla Hwalla ^a   Torbay, Naji ^a   Dib, Lea ^a   Fuleihan, Ghada El Hajj ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; ESTROGEN; INSULIN; LEPTIN; OSTEOCALCIN; SOMATOMEDIN C; TESTOSTERONE;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; ESTROGEN BLOOD LEVEL; FEMALE; HIP; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; MUSCLE MASS; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; SPINE; TESTOSTERONE BLOOD LEVEL;

ADOLESCENT; ADULT; BONE DENSITY; BONE REMODELING; COLLAGEN; FEMALE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MIDDLE AGED; OBESITY; PREMENOPAUSE;

EID: 18844439138     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-2049     Document Type: Article

References (65)

1. Seeman E, Melton 3rd LJ, O'Fallon WM, Riggs BL 1983 Risk factors for spinal osteoporosis in men. Am J Med 75:977-983
2. Riggs BL, Melton 3rd LJ 1986 Involutional osteoporosis. N Engl J Med 314:1676-1686
3. Melton 3rd LJ, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL 1989 Epidemiology of vertebral fractures in women. Am J Epidemiol 129:1000-1011
4. Rubin CT, Lanyon LE 1985 Regulation of bone mass by mechanical strain magnitude. Calcif Tissue Int 37:411-417
5. Frumar AM, Meldrum DR, Geola F, Shamonki IM, Tataryn IV, Deftos LJ, Judd HL 1980 Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women. J Clin Endocrinol Metab 50:70-75
6. Johnston Jr CC, Hui SL, Longcope C 1985 Bone mass and sex steroid concentrations in postmenopausal Caucasian diabetics. Metabolism 34:544-550
7. Reid IR, Evans MC, Cooper GJ, Ames RW, Stapleton J 1993 Circulating insulin levels are related to bone density in normal postmenopausal women. Am J Physiol 265:E655-E659
8. Cock TA, Auwerx J 2003 Leptin: cutting the fat off the bone. Lancet 362:1572-1574
9. Froesch ER, Schmid C, Schwander J, Zapf J 1985 Actions of insulin-like growth factors. Annu Rev Physiol 47:443-467
10. Barrett-Connor E, Kritz-Silverstein D 1996 Does hyperinsulinemia preserve bone? Diabetes Care 19:1388-1392
11. Akune T, Ogata N, Hoshi K, Naoto K, Terauchi Y, Tobe K, Takagi H, Azuma Y, Kadowaki T, Nakamura K, Kawaguchi H 2002 Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J Cell Biol 159:147-156
12. Ogata N, Chikazu D, Kubota N, Terauchi Y, Tobe K, Azuma Y, Ohta T, Kadowaki T, Nakamura K, Kawaguchi H 2000 Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 105:935-943
13. Reid IR, Cornish J 2004 Direct actions of leptin on bone remodeling. Calcif Tissue Int 74:313-316
14. Ruhl C, Everhart J 2002 Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 17:1896-1903
15. Reseland JE, Gordeladze JO 2002 Role of leptin in bone growth: central player or peripheral supporter? FEBS Lett 528:40-42
16. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197-207
17. Thomas T, Gori F, Spelsberg TC, Khosla S, Riggs BL, Conover CA 1999 Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. Endocrinology 140:5036-5044
18. Holloway WR, Collier FM, Aitken CJ, Myers DE, Hodge JM, Malakellis M, Gough TJ, Collier GR, Nicholson GC 2002 Leptin inhibits osteoclast generation. J Bone Miner Res 17:200-209
19. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H 2004 PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113:846-855
20. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsushida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T 2001 The mechanisms by which both heterozygous peroxisome proliferators-activated receptor γ (PPAR γ) deficiency and PPAR γ agonist improve insulin resistance. J Biol Chem 276:41245-41254
21. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R 2003 Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 26:3320-3325
22. Matthews DR, Hosker JP, Rudenski AS, Naylao BA, Treacher DF, Turner AC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:412-419
23. Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G, Quon MJ 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410
24. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, Duncan AW 2001 Diagnosing insulin resistance in the general population. Diabetes Care 24:460-464
25. El-Hajj Fuleihan G, Testa M, Angell J, Porrino N, LeBoff MS 1995 Reproducibility of DEXA densitometry: a model for bone loss estimates. J Bone Miner Res 10:1004-1014
26. El-Hajj Fuleihan G, Baddoura R, Awada H, Salam N, Salamoun M, Rizk P 2002 Low peak bone mineral density in healthy Lebanese subjects. Bone 31:520-528
27. Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RA, Wilson TA 1995 Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellirus. J Clin Endocrinol Metab 80:1312-1317
28. Rishaug U, Birkeland KI, Falch JA, Vaaler S 1995 Bone mass in non-insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 55:257-262
29. Nowicki M, Kokot F, Surdacki A 1998 The influence of hyperinsulinemia on calcium-phosphate metabolism in renal failure. Nephrol Dial Transplant 13:2566-2571
30. Thomas DM, Ng KW, Best JD 1997 Insulin and bone: a clinical and scientific review. Endocrinol Metab 4:5-17
31. Di Carlo C, Shoham Z, MacDougall J, Patel A, Hall ML, Jacobs HS 1992 Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea. Fertil Steril 57:314-319
32. Dagogo-Jack S, al-Ali N, Qurttom M 1997 Augmentation of bone mineral density in hirsute women. J Clin Endocrinol Metab 82:2821-2825
33. Good C, Tulchinsky M, Mauger D, Demers LM, Legro RS 1999 Bone mineral density and body composition in lean women with polycystic ovary syndrome. Fertil Steril 72:21-25
34. Adami S, Zamberlan N, Castello R, Tosi F, Gatti D, Moghetti P 1998 Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women. Clin Endocrinol (Oxf) 48:169-173
35. Thomas T, Burguera B, Melton 3rd LJ, Atkinson EJ, O'Fallon WM, Riggs BL, Khosla S 2001 Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 29:114-120
36. Yuksel O, Dokmetas HS, Topcu S, Erselcan T, Sencan M 2001 Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome. J Bone Miner Metab 19:257-262
37. Widjaja A, Stratton IM, Horn R, Holman R, Turner R, Brabant G 1997 UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab 82:654-657
38. Rentsch J, Chiesi M 1996 Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett 379:55-59
39. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Ciraid J, Staels B, Auwerx J 1995 Transient increase in obese gene expression after food intake or insulin administration. Nature 377:527-529
40. Iwamoto I, Douchi T, Kosha S, Murakami M, Fujino T, Nagata Y 2000 Relationships between serum leptin level and regional bone mineral density, bone metabolic markers in healthy women. Acta Obstet Gynecol Scand 79:1060-1064
41. Odabasi E, Ozata M, Turan M, Bingol N, Yonem A, Cakir B, Kutlu M, Ozdemir IC 2000 Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol 142:170-173
42. Sato M, Takeda N, Sarui H, Takami R, Takami K, Hayashi M, Sasaki A, Kawachi S, Yoshino K, Yasuda K 2001 Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. J Clin Endocrinol Metab 86:5273-5276
43. Blum M, Harris SS, Must A, Naumova EN, Phillips SM, Rand WM, Dawson-Hughes B 2003 Leptin, body composition and bone mineral density in premenopausal women. Calcif Tissue Int 73:27-32
44. Martini C, Valenti R, Ciovani S, Fraud B, Campagna S, Nuti R 2001 Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone 28:113-117
45. Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, Riggs BL, Turner RT 2001 Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142:3546-3553
46. Cornish J, Gallon KE, Bava U, Lin C, Naot D, Hill BL, Grey AB, Broom N, Meyers DE, Nicholson GC, Reid IR 2002 Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175:405-415
47. Chen Z, Lohman TG, Stini WA, Ritenbaugh C, Aickin M 1997 Fat or lean tissue mass: Which one is the major determinant of bone mineral mass in healthy postmenopausal women? J Bone Miner Res 12:144-151
48. Salamone LM, Glynn N, Black D, Epstein RS, Palermo L, Meilahn E, Kuller LH, Cauley JA 1995 Body composition and bone mineral density in premenopausal and early perimenopausal women. J Bone Miner Res 10:1762-1768
49. Reid IR, Ames R, Evans MC, Sharpe S, Gamble G, France JT, Lim TM, Cundy TF 1992 Determinants of total and regional bone mineral density in normal post menopausal women: a key role for fat mass. J Clin Endocrinol Metab 75:45-51
50. Khosla S, Atkinson E, Riggs L, Melton LJ 1996 Relationship between body composition and bone mass in women. J Bone Miner Res 11:857-863
51. Considine RV, Sinha MK, Herman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295
52. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161
53. Thomas T, Burguera B, Melton III LJ, Atkinson EJ, Riggs BL, Khosla S 2000 Relationship of serum leptin levels with body composition, sex steroid, and insulin levels in men and women. Metabolism 49:1278-1284
54. Coulding A, Taylor RW 1998 Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 63:456-458
55. Yamauchi M, Sugimoto T, Yamaguchi T, Nakaoka D, Kanzawa M, Yano S, Ozuru R, Sugishita T, Chihara K 2001 Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in post-menopausal women. Clin Endocrinol (Oxf) 55:341-347
56. Pasco JA, Henry MJ, Kotowicz MA, Collier GR, Ball MJ, Ugoni AM, Nicholson GC 2001 Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 86:1884-1887
57. Reid IR, Plank LD, Evans MC 1992 Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab 75:779-782
58. Lindsay R, Cosman F, Herrington BS, Himmelstein S 1992 Bone mass and body composition in normal women. J Bone Miner Res 7:55-63
59. Edelstein SL, Barrett-Connor E 1993 Relation between body size and bone mineral density in elderly men and women. Am J Epidemiol 138:160-169
60. Glauber HS, Vollmer WM, Nevitt MC, Ensrud KE, Orwoll ES 1995 Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J Clin Endocrinol Metab 80:1118-1123
61. Conover CA 1996 The role of insulin-like growth factors and binding proteins in bone cell biology. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. San Diego: Academic Press; 607-678
62. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV 1996 Decreased cerebrospinal fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159-161
63. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte Jr D 1996 Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2:589-593
64. Suzuki K, Ishida H, Takeshita N, Taguchi Y, Sugimoto C, Nosaka K, Seino Y 1998 Circulating levels of tartrate-resistant acid phosphatase in rat models of non-insulin-dependent diabetes mellitus. J Diabetes Complications 12:176-180
65. Svedberg J, Bjorntorp P, Smith U, Lonnroth P 1990 Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39:570-574